e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Novel drugs under development for the treatment of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduction of rhinovirus 16-induced epithelial ICAM-1 expression by cilomilast (Ariflo)
J. Zhu, S. D. Message, M. Edwards, J. R. Dave, P. Taylor, S. L. Johnston, P. K. Jeffery (London, United Kingdom)
Source:
Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases
Session:
Novel drugs under development for the treatment of respiratory diseases
Session type:
Oral Presentation
Number:
2556
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Zhu, S. D. Message, M. Edwards, J. R. Dave, P. Taylor, S. L. Johnston, P. K. Jeffery (London, United Kingdom). Reduction of rhinovirus 16-induced epithelial ICAM-1 expression by cilomilast (Ariflo). Eur Respir J 2003; 22: Suppl. 45, 2556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of cilomilast on rhinovirus 16-induced IL6, IL8 and RANTES production by bronchial epithelium
Source: Eur Respir J 2005; 26: Suppl. 49, 97s
Year: 2005
Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells
Source: Eur Respir J 2012; 40: 122-132
Year: 2012
Modulation of TNFα-induced ICAM-1 expression in a human bronchial epithelial cell line (Beas-2B) by roflumilast N-oxide (RNO), salmeterol (Sal) and budesonide (Bud)
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
Dexamethasone and formoterol modulate human rhinovirus induced MMP-9 expression
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Effects of PDE4 inhibitors on eotaxin-3 (CCL26) expression in lung epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable
Haemophilus influenzae
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Modulation of ICAM-1 receptors by cyclic stretch in airway epithelial cells; influence of rhinovirus infection
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
Source: Eur Respir J 2006; 27: 12-19
Year: 2006
Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE)
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells
Source: Eur Respir J 2006; 28: 51-58
Year: 2006
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Azithromycin differentially affects IL-13 induced periostin (POSTN), CLCA1 and SERPINB2 expression in human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Effect of roflumilast N-oxide on non-typable
haemophilus influenzae
(NTHi) interaction with human airway epithelial A549 cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Regulation of
Mycoplasma pneumoniae
lysate-induced IL-8 expression in human airway epithelial cells
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression
Source: Eur Respir J 2001; 18: 139-145
Year: 2001
Effects of IL-4 and neutrophil defensins (HNP1-3) on differentiation of primary bronchial epithelial cells (PBEC)
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept